William Boden, MD
Professor
Boston University School of Medicine
Dept of Medicine
Cardiovascular Medicine

MD, State University of New York at Brockport




I am ABIM board-certified in both Internal Medicine and the subspecialty of Cardiovascular Disease. Since 1979, I have held university appointments at Brown University, Wayne State University, Tufts New England Medical Center, Boston University, the University of Connecticut, State University of New York in Buffalo, and Albany Medical College. For the past 27 consecutive years, I have held leadership roles as either a Chief of cardiology or Chief of Medicine at both federal VA facilities and in the academic private sector, all of which have had strong affiliations with their respective academic health centers. In 2016, I re-joined the VA Boston MAVERIC Center as the Scientific Director, Clinical Trials Network, for the VA New England Healthcare System, and as the Research Lead Physician, for VISN 1.

I have extensive prior experience in clinical trials and comparative effectiveness research, and have served in a leadership capacity in several important national and international clinical trials, including as Study Chair for VA CSP-funded VANQWISH and COURAGE Trials, as Study Co-Chair of the NIH-funded AIM-HIGH Trial, and as a national co-PI for the NIH-funded ISCHEMIA Trial. My principal research interests include studies in stable ischemic heart disease, post-MI secondary prevention, acute coronary syndromes, and preventive cardiology.

Lecturer in Medicine
Harvard Medical School


Physician Research Lead & Scientific Director
VA Boston Healthcare System
MAVERIC Center
Clinical Trials Network


2012-2015 Greater Albany Capital Region/Hudson Valley, NY: Selected as one of the “Best Doctors in Cardiovascular Medicine"
2008 D’Youville College, Buffalo, NY: Thirteenth Annual Award for Achievement in Health Care
2002-2004 Connecticut Magazine and Hartford Magazine: Selected as one of the top Cardiology physicians in Connecticut
2001-2015 Selected for inclusion in “Best Doctors in America” (15 consecutive years)
2001-2002 Hartford Hospital: Outstanding Teacher of the Year in Cardiology
1994 Boston University Medical Center/VAMC: Medical House Staff Award for Outstanding Clinical Teacher of the Year
1992 Boston University Medical Center/VAMC: Medical House Staff Award for Outstanding Clinical Teacher of the Year
1985 Miriam Hospital: Medical House Staff Award for Outstanding Clinical Teaching
1984-1986 Rhode Island Department of Health: Principal Consultant, Cardiovascular Diseases
1983 American Heart Association: Cardiovascular Research Grant-in-Aid
1978 American College of Cardiology: Young Investigators' Award Finalist
1977 American Heart Association: Cardiovascular Research Grant-in-Aid
1977-1979 Tufts Medical Center: Cardiology Fellowship
1976 National Heart, Lung and Blood Institute: Individual Postdoctoral Research Fellowship in Cardiovascular Diseases
1976-1977 University Hospital (Boston Medical Center): Chief Medical Residency
1974-1976 University Hospital (Boston Medical Center): Medical Residency
1974 Alpha Omega Alpha Medical Honor Society
1969 National Jesuit Collegiate Honor Society: Alpha Sigma Nu

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Boden WE, Gersh BJ. Defining the Proper SYNTAX for Long-Term Benefit of Myocardial Revascularization With Optimal Medical Therapy. J Am Coll Cardiol. 2021 Jul 06; 78(1):39-41. PMID: 34210412
     
  2. Brown DL, Boden WE. Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases? Eur Heart J. 2021 Jun 10. PMID: 34110408
     
  3. Boden WE. RESPONSE: The Exit Interview-of a Professional Lifetime. J Am Coll Cardiol. 2021 May 04; 77(17):2256-2257. PMID: 33926662
     
  4. White HD, O'Brien SM, Alexander KP, Boden WE, Bangalore S, Li J, Manjunath CN, Lopez-Sendon JL, Peteiro J, Gosselin G, Berger JS, Maggioni AP, Reynolds HR, Hochman JS, Maron DJ. Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial. JAMA Cardiol. 2021 May 03. PMID: 33938917; PMCID: PMC8094032; DOI: 10.1001/jamacardio.2021.1651;
     
  5. Shah R, Nayyar M, Le FK, Labroo A, Nasr A, Rashid A, Davis DA, Weintraub WS, Boden WE. A meta-analysis of optimal medical therapy with or without percutaneous coronary intervention in patients with stable coronary artery disease. Coron Artery Dis. 2021 Apr 19. PMID: 33878073
     
  6. Gersh BJ, Boden WE, Bhatt DL, Stone PH, Crea F, Lüscher TF. To stent or not to stent? Treating angina after ISCHEMIA-introduction. Eur Heart J. 2021 04 07; 42(14):1387-1388. PMID: 33827136
     
  7. Boden WE, Stone PH. To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial. Eur Heart J. 2021 04 07; 42(14):1394-1400. PMID: 33827137
     
  8. Handberg EM, Merz CNB, Cooper-Dehoff RM, Wei J, Conlon M, Lo MC, Boden W, Frayne SM, Villines T, Spertus JA, Weintraub W, O'Malley P, Chaitman B, Shaw LJ, Budoff M, Rogatko A, Pepine CJ. Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial. Am Heart J. 2021 Jul; 237:90-103. PMID: 33745898
     
  9. McCreanor V, Nowbar A, Rajkumar C, Barnett AG, Francis D, Graves N, Boden WE, Weintraub WS, Al-Lamee R, Parsonage WA. Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial. BMJ Open. 2021 02 09; 11(2):e044054. PMID: 33563623; PMCID: PMC7875263; DOI: 10.1136/bmjopen-2020-044054;
     
  10. Bossard M, Gao P, Boden W, Steg G, Tanguay JF, Joyner C, Granger CB, Kastrati A, Faxon D, Budaj A, Pais P, Di Pasquale G, Valentin V, Flather M, Moccetti T, Yusuf S, Mehta SR. Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease. Heart. 2021 Jan 27. PMID: 33504513
     
Showing 10 of 343 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 340 publications over 42 distinct years, with a maximum of 22 publications in 2020

YearPublications
19801
19813
19821
19834
19842
19853
19863
19876
19882
19897
19905
19915
19928
19932
19942
19953
19963
19971
19984
19991
20008
200111
200210
20036
20048
20055
200611
20076
200817
200919
201015
201113
201215
201320
201410
201514
201615
20179
201816
201913
202022
202111
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Stable ischemic heart disease
Post-MI secondary prevention
Acute Coronary Syndromes
Preventive cardiology
Contact for Mentoring:

150 South Huntington Avenue
Boston MA 02130
Google Map


Boden's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department